Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,096.00    -34.00 (-0.82%)
Bid:
4,072.00
Ask:
4,080.00
Spread: 8.00 (0.196%)
Market Cap: £4.30b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Directorate Change

13 Feb 2018 09:00

RNS Number : 6551E
Computacenter PLC
13 February 2018
 

Computacenter plc

Incorporated in England and Wales

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

FOR IMMEDIATE RELEASE

 

Computacenter plc

 

Directorate Change

 

Computacenter plc (the "Company") announces the appointment of Peter Ryan to the Board as a Non-Executive Director with immediate effect.

 

Peter has had a successful 37 year international career in technology encompassing all dimensions of the industry including software, services, systems integration, outsourcing and infrastructure. Over the last 10 years, Peter has held roles such as Chief Sales Officer with Hewlett Packard Enterprise, Chief Client Officer at Logica plc and Executive Vice President, Global Sales and Services with Sun Microsystems Inc. After starting his career at the Home Office, Peter undertook various senior management roles with Aspect Group Ltd, Parametric Technology Ltd, IBM (UK) Ltd and ICL plc.

 

The Chairman of Computacenter, Greg Lock, commented:

 

"I am pleased to welcome Peter to our Board. His successful management of, and significant technology expertise within, large global enterprises will be an asset to our Board and the Company."

 

Note:

 

This announcement is made pursuant to Listing Rule 9.6.11. In accordance with LR 9.6.13R of the Listing Rules, Computacenter confirms that there is no information to be disclosed in terms of LR 9.6.13R (2) to LR 9.6.13R (6) inclusive in respect of Peter Ryan.

 

Enquiries

 

Computacenter plc

 

Mike Norris, Chief Executive

 

01707 631601

Tony Conophy, Finance Director

01707 631515

 

Tulchan Communications

 

James Macey White

020 7353 4200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUURORWOAUAUR
Date   Source Headline
1st Aug 20246:03 pmRNSTransaction in Own Shares
1st Aug 202412:00 pmRNSTotal Voting Rights
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
31st Jul 20246:21 pmRNSTransaction in Own Shares
30th Jul 20246:22 pmRNSTransaction in Own Shares
30th Jul 202410:15 amRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:10 amRNSShare Buyback Programme – 26 July 2024
26th Jul 20247:00 amRNSTrading Update and Return of Value – 26 July 2024
2nd Jul 202410:00 amRNSDirectorate Change -Confirmation of Effective Date
5th Jun 20247:00 amRNSCapital Markets Day
14th May 20242:00 pmRNSResult of AGM
1st May 20247:00 amRNSQ1 Trading Update
11th Apr 20241:00 pmRNS2023 Annual Financial Report & Notice of 2024 AGM
5th Apr 20247:00 amRNSDirectorate Change - Holding Announcement
4th Apr 20243:00 pmRNSDirector/PDMR Shareholding
27th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSChange of Chair
20th Mar 20247:00 amRNSFinal Results 2023
5th Feb 20241:00 pmRNSBlock listing Interim Review
24th Jan 20247:00 amRNSPre-Close Trading Statement
30th Oct 202311:00 amRNSQ3 2023 Trading Update Replacement
30th Oct 20237:05 amRNSAppointment of Corporate Broker
30th Oct 20237:00 amRNSQ3 2023 Trading Update
17th Oct 20231:00 pmRNSDirector/PDMR Shareholding
12th Sep 202311:00 amRNSDirector/PDMR Shareholding
8th Sep 20237:00 amRNSHalf-year Report
8th Aug 202311:30 amRNSBlock listing Interim Review
14th Jun 202312:00 pmRNSHolding(s) in Company
7th Jun 202312:00 pmRNSDirector/PDMR Shareholding
6th Jun 20234:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSQ1 2023 Trading Update
17th Apr 20231:31 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20233:15 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSDirector/PDMR Shareholding
31st Mar 20231:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSFinal Results 2022
28th Mar 20237:00 amRNSFY2022 results release date - UPDATE
14th Mar 20237:00 amRNSFY2022 results revised date; guidance unchanged
2nd Mar 202310:00 amRNSHolding(s) in Company
17th Feb 202310:00 amRNSHolding(s) in Company
9th Feb 20239:30 amRNSHolding(s) in Company
6th Feb 202311:15 amRNSBlock listing Interim Review
30th Jan 20237:00 amRNSPre-Close Trading Statement
9th Dec 202212:30 pmRNSDirectorate Change - Update
9th Dec 202212:00 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.